271 Shares in Axon Enterprise, Inc $AXON Purchased by First Financial Group Corp

First Financial Group Corp bought a new position in Axon Enterprise, Inc (NASDAQ:AXON) during the second quarter, Holdings Channel reports. The firm bought 271 shares of the biotechnology company’s stock, valued at approximately $224,000.

A number of other hedge funds also recently made changes to their positions in AXON. TCTC Holdings LLC lifted its position in shares of Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after buying an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC lifted its position in shares of Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after buying an additional 33 shares in the last quarter. Banque Transatlantique SA purchased a new stake in shares of Axon Enterprise in the first quarter worth about $31,000. Catalyst Capital Advisors LLC purchased a new stake in shares of Axon Enterprise in the first quarter worth about $32,000. Finally, Flaharty Asset Management LLC purchased a new stake in shares of Axon Enterprise in the first quarter worth about $33,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction that occurred on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the transaction, the chief financial officer owned 93,592 shares of the company’s stock, valued at $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 15,919 shares of the stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the transaction, the president directly owned 238,379 shares in the company, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 49,932 shares of company stock valued at $37,978,216 over the last 90 days. 5.70% of the stock is owned by insiders.

Analyst Ratings Changes

AXON has been the topic of several analyst reports. Piper Sandler initiated coverage on Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 price objective on the stock. JPMorgan Chase & Co. boosted their price objective on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research note on Thursday, July 17th. Morgan Stanley set a $885.00 price objective on Axon Enterprise and gave the stock an “overweight” rating in a research note on Friday, July 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Axon Enterprise in a research note on Saturday, September 27th. Finally, Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $841.64.

Axon Enterprise Trading Down 1.0%

AXON opened at $714.60 on Wednesday. The stock has a market cap of $56.10 billion, a price-to-earnings ratio of 176.44, a P/E/G ratio of 28.02 and a beta of 1.41. The stock’s 50 day moving average price is $757.21 and its 200-day moving average price is $710.53. Axon Enterprise, Inc has a one year low of $420.49 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. During the same quarter in the prior year, the firm posted $1.20 earnings per share. The company’s quarterly revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.